Greater Orlando is on a remarkable roll. According to the Orlando Economic Partnership, the region has earned what it calls a “Triple Crown” distinction, leading the entire nation in job growth, population growth, and GDP growth simultaneously. That kind of across-the-board momentum is rare for any metro area, and it signals that Orlando’s economy is firing on all cylinders heading into the new year.

The good news doesn’t stop there. The Orlando area is also welcoming a significant new employer: global pharmaceutical giant Novartis has selected Winter Park as the site for a new radioligand therapy manufacturing facility. Radioligand therapy is an advanced, targeted approach to treating cancer, placing this facility squarely at the cutting edge of modern medicine. The choice of Winter Park — and the broader Orlando region — reflects the area’s growing reputation as a destination for high-skilled, high-impact industries.

Together, these two developments paint a vivid picture of a community that is not only growing in size but growing in the quality and diversity of its economy. Residents can take pride in knowing that their region is attracting world-class investment while simultaneously leading the country in the metrics that matter most to everyday quality of life: jobs, people, and economic output.

Both announcements were highlighted by the Orlando Economic Partnership, the organization that works to strengthen and promote the region’s business climate. With milestones like these, it’s clear that Orlando’s future is as bright as its famous sunshine.

Sources: Orlando Economic Partnership, Orlando Economic Partnership